Recent News

Carbon Ion Radiation Therapy for Mesothelioma

January 27, 2023

A specific type of radiation could be useful for the treatment of mesothelioma. Carbon-ion beam irradiation along with the chemotherapy drug cisplatin could potentially stop the growth of pleural mesothelioma…

Legacy Asbestos More Dangerous than Previously Thought

January 20, 2023

A United Kingdom study is showing the dangers of legacy asbestos. Asbestos that remains in commercial and residential buildings can be more dangerous than previously thought. Researchers from the study…

Pleurectomy and Decortication is the Best Option for Bicavity Surgery on Peritoneal Mesothelioma

January 13, 2023

Patients with thoracic and abdominal mesothelioma can extend survival when they are given aggressive surgery. This news came from a study at Baylor College of Medicine in Houston. When patients…

A Treatment Involving Checkpoint Inhibitors Before Surgery is Showing Promising Results for Mesothelioma

January 6, 2023

Immunotherapy before aggressive surgery shows great promise for pleural mesothelioma. The combination has shown that it can improve survival for a group of patients with pleural mesothelioma in a phase…

Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma (HIT-Meso)

December 16, 2022

Primary Outcome Measures Progression free survival [ Time Frame: From randomisation up to 2 years of follow up ] Defined as the time from randomisation to the date of disease progression Overall survival [ Time Frame: From…

Timely Treatment for Mesothelioma Could Improve Survival

December 16, 2022

It is best to treat peritoneal mesothelioma as soon as possible. Waiting to receive treatment could prevent a patient from living longer than possible. Information from a study looking at…

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

December 9, 2022

Primary Outcome Measures Maximum Tolerated Dose (MTD) and/or Maximum Administered Dose (MAD) [ Time Frame: 28 days during 1st cycle ] Determine the MTD and/or MAD of anti GP88 monoclonal antibody (AG-01) in subjects…

Mesothelioma Rates Increased Over a 30 Year Period

December 9, 2022

Mesothelioma diagnoses have almost doubled in the last 30 years, highlighting the need for better care and more ways to regulate and reduce asbestos exposure. There were around 35,000 people…

Study Found Lung Removing Surgery for Mesothelioma Can be More Effective in Some Patients

December 2, 2022

The most aggressive surgery for mesothelioma could be more beneficial for patients with the disease. The more aggressive surgery is called an extrapleural pneumonectomy (EPP), which involves removing the lung.…

Gavo-Cel Moving to Phase II Trial for Mesothelioma

November 18, 2022

A study looking at T-cell therapy for mesothelioma is going to phase II of the clinical trial process. Researchers are trying to find out how effective the treatment is when…